Drug Repositioning - GEN - Genetic Engineering and Biotechnology News

wound care

Drug Repositioning

Circadian Clock Gene Inhibition by FDA-Approved Drugs Could Improve Scar Healing

Drug Repositioning

Pulmonary Edema Could Be Countered by Cystic Fibrosis Drug

Drug Repositioning

Repurposed Cardiovascular Drugs May Aid Acute Kidney Injury

Drug Repositioning

Anti-Diarrheal Drug Identified as Potential Therapy for Core Autism Symptoms

Drug Repositioning

Repurposed Drug Shows Preclinical Promise against Amyotrophic Lateral Sclerosis

Drug Repositioning

Preclinical Study Demonstrates Effective Oral Treatment against Hepatitis A Virus

Drug Repositioning

Common HIV Treatment Improves Cognition in Down Syndrome Mice

Thalidomide

Drug Repositioning

Thalidomide Effectively Treats Damaging Blood Vessel Disorder in Humans

Dual-mechanism oral small molecule MBX-2982 acts as GPR119 agonist. [© Celso Pupo - Fotolia.com]

Drug Repositioning

Anticancer Candidate Relieves Beta Cell Overload, Reverses Diabetes in Mice

eye

Drug Repositioning

Antabuse May Help Revive Sight in People with Blinding Disorders

Woman Receiving Radiation Therapy Treatments for Head & NeckCancer

Drug Repositioning

Malaria Drug Could Combat Head and Neck Cancer Chemotherapy Resistance

Drug Repositioning

T1D Patients Benefit from Blood Pressure Drug in Two-Year Study

coronavirus

Drug Repositioning

COVID-19 Proteases Inhibited by Repurposed FDA-Approved Drugs

[iStock/FredFroese]

Drug Repositioning

Anticancer Drug Promotes Weight Loss in Obese Mice

T-Cells Work to Fight Cancer, Immunotherapy, CAR T-cell therapy, 3d renderin

On Demand Webinars

Efficacy of Polyfunctional GD3 CAR T Cells against Rare Tumors

12 3...10 Page 1 of 10